跳至主要内容
临床试验/NCT05422144
NCT05422144撤回不适用

BIAKOS Antimicrobial Wound Cleanser and BIAKOS Antimicrobial Wound Gel: Providing Biofilm Prevention and Treatment Through Continuum of Care

Rochal Industries LLC2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
35
试验地点
2
主要终点
Microbial Load

研究概览

简要总结

The proposed study will be a prospective trial of management of acute traumatic wounds (less than 24 hours from injury and without previous intervention aside from a dressing for coverage). The study design involves a prospective single arm, 35 subject study that analyzes the effect of the subsequent application of a novel wound cleanser and wound gel on subjects' acute traumatic wounds and the respective microbial loads over a 28 day study duration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18 to 89 years old.
  • Patients receiving care in the ED/trauma bay or admitted to Brooke Army Medical Center (BAMC) from the ED or trauma bay.
  • At least one wound area must measure equal to or greater than 2cm^2 to include partial or full thickness tears.
  • Wound sustained less than 48-hours from time of enrollment.
  • The wound must be untreated/open beyond bedside stabilization such as irrigation and debridement (i.e., no stitches, steristrips, dermabond, OR washouts, etc).
  • Capable of providing informed written consent by self or through Legally Authorized Representative (LAR).
  • Ability to read/speak English (participant and/ or LAR).

排除标准

  • Ages less than 18 or greater than 89 years old.
  • Patients not receiving care in the ED/trauma bay or admitted to BAMC through the ED or trauma bay.
  • Wound area less than 2 cm
  • Wound sustained greater than 48-hours from the time of enrollment.
  • Wounds that have been closed/repaired at the time of screening (i.e. stitches, steristrips, dermabond, washouts in the OR, etc.) or anytime during the study duration.
  • Not capable of providing informed written consent by self or through LAR.
  • Non-English reading and speaking (participant and/or LAR).
  • Have received more than one dose of antibiotics prior to enrollment or during the study duration.
  • Suspected or confirmed signs/symptoms of active wound infection or gangrene.
  • Patients with osteomyelitis.
  • Wounds with exposed tendons, ligaments, or bone.
  • Patients undergoing active renal dialysis.
  • Patients receiving (within 30 days of enrollment) or scheduled to receive a medication or treatment which is known to negatively affect wound healing such as systemic steroids (i.e. continuous prednisone), immunosuppressive therapy, chemotherapy, autoimmune disease therapy, cytostatic therapy, vascular surgery, angioplasty, or thrombolysis.
  • Pregnant, breastfeeding, or women of childbearing potential who do not agree to use an effective form of contraception during their participation in the study.
  • Participation in another investigational device, drug, or biological trial that may interfere with results within 30 days of screening.
  • Anyone deemed by the PI to be unlikely to comply with all study procedures.

结局指标

主要结局

Microbial Load

时间窗: 28 days

As indicated semi-quantitatively by MicroGenDx/ Research and Testing Labs LLC (RTL) swab collection and qualitatively by visual assessments and MolecuLight i:X images.

次要结局

  • Wound Healing Rates(28 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验